Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Pietrini, P. Articles by Schapiro, M. B. Search for Related Content PubMed Citation Articles by Pietrini, P. Articles by Schapiro, M. B. Alzheimer's Disease PET

Association Between Brain Functional Failure and Dementia Severity in Alzheimer's Disease: Resting Versus Stimulation PET Study

OBJECTIVE: This study tested the hypothesis that regional cerebral glucose metabolism during neuronal activation is a more sensitive index of neuronal dysfunction and clinical severity in Alzheimer's disease than is glucose metabolism at rest. METHOD: The subjects were 15 Alzheimer's disease patients with a wide range of Mattis Dementia Rating Scale scores (23–128). By using positron emission tomography, absolute glucose metabolism was measured in the parietal, occipital (visual areas), and temporal (auditory areas) cortical regions during rest (eyes/ears covered) and audiovisual stimulation. RESULTS: In the parietal cortex, glucose metabolism correlated with dementia severity in both conditions. In contrast, in the relatively preserved visual and auditory cortical regions, glucose metabolism predicted dementia severity during stimulation but not at rest. CONCLUSIONS: These findings suggest that regional cerebral glucose metabolism during stimulation is a more sensitive index of the functional/metabolic failure of neuronal systems than is metabolism at rest. (Am J Psychiatry 1999; 156:470–473)

This article has been cited by other articles:

				M. A. Yassa, G. Verduzco, C. Cristinzio, and S. S. Bassett Altered fMRI activation during mental rotation in those at genetic risk for Alzheimer disease Neurology, May 13, 2008; 70(20): 1898 - 1904. [Abstract] [Full Text] [PDF]

				X. Chen, V. A. Magnotta, K. Duff, L. L. Boles Ponto, and S. K. Schultz Donepezil Effects on Cerebral Blood Flow in Older Adults With Mild Cognitive Deficits J Neuropsychiatry Clin Neurosci, May 1, 2006; 18(2): 178 - 185. [Abstract] [Full Text] [PDF]

				J. F. Norfray and J. M. Provenzale Alzheimer's Disease: Neuropathologic Findings and Recent Advances in Imaging Am. J. Roentgenol., January 1, 2004; 182(1): 3 - 13. [Full Text] [PDF]

				B. Matthews, E. R. Siemers, and P. D. Mozley Imaging-Based Measures of Disease Progression in Clinical Trials of Disease-Modifying Drugs for Alzheimer Disease Am J Geriatr Psychiatry, April 1, 2003; 11(2): 146 - 159. [Abstract] [Full Text] [PDF]

				A. L. W. Bokde, P. Pietrini, V. Ibanez, M. L. Furey, G. E. Alexander, N. R. Graff-Radford, S. I. Rapoport, M. B. Schapiro, and B. Horwitz The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease Arch Neurol, March 1, 2001; 58(3): 480 - 486. [Abstract] [Full Text] [PDF]

				F. Fazio and D. Perani Importance of Partial-Volume Correction in Brain PET Studies J. Nucl. Med., November 1, 2000; 41(11): 1849 - 1850. [Full Text] [PDF]

				C. C. Meltzer Neuropharmacology and Receptor Studies in the Elderly J Geriatr Psychiatry Neurol, October 1, 1999; 12(3): 137 - 149. [Abstract] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us